Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P59.21 - Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Melina E. Marmarelis
- Abstract
Loading...
-
+
MA06 - Differentiating Outcomes and Impact in Unresectable NSCLC
- 09:30 - 10:30
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Locally Advanced Non-Small Cell Lung Cancer
-
+
MA06.01 - Death From Intercurrent Disease After Proton- Versus Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer
09:30 - 09:35 | Presenter: Nikhil Yegya-Raman
- Abstract
Loading...
-
+
OA09 - Expanding Immunotherapy Options for Non-Small Cell Lung Cancers
- 09:30 - 10:30
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Moderators:Rina Hui
-
+
OA09.04 - Discussant
10:00 - 10:10 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Moderators:Sarah B Goldberg
-
+
OA16.01 - Plasma NGS At Time of Diagnostic Tissue Biopsy – Impact on Time to Treatment: Results From a Pilot Prospective Study
20:00 - 20:10 | Presenter: Jeffrey C. Thompson
- Abstract
Loading...